Brett Guthrie voted yes on 100% of tracked bills classified as favoring Pharmaceuticals & Biotech and Telecommunications—the third-highest rate among House members with sufficient votes on such legislation. He voted yes on HR3537-117, which sought to accelerate access to therapies for ALS patients, a bill classified as favoring the pharmaceutical sector, though he voted yes on 4 of 5 bills classified as limiting those same industries.

EXAMPLE VOTES BEHIND THE NUMBER
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
SJRES28-119 — A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection re
FOLLOW THE TRAIL
◈ Ask the Analyst about Brett Guthrie →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 19, 2026 · internal signal score 94/100.